Redeye Feed

2026-11-02 14:16:00 Alligator Bioscience: Mitazalimab sold to Biossil

2026-11-02 14:14:00 Paxman: First CIPN order

2026-11-02 14:13:00 CTEK (Q3 Review): Back to growth, margins keep surprising

2026-11-02 14:12:00 Indutrade (Q3 review): Orders keep building

2026-10-30 14:16:00 Enviro (Q3 Review): Reconstruction enters its final phase

2026-10-30 14:15:00 Transtema (Q3 Preliminary): Sweden solid, Norway sees significant decline and is written down

2026-10-30 14:14:00 CLS: Industry partner in NCI-funded programme for spinal metastases

2026-10-30 14:13:00 BioInvent (Q3 Review): Rights Issue to Fund Part C

2026-10-30 14:12:00 Senzime (Q3 Review): Recovery under way

2026-10-30 14:11:00 Lifco (Q3 Review): Margins hold, but a customer leaves

2026-10-29 18:12:00 Sdiptech (Q3 review): Sales beat, Base Case raised to SEK315

2026-10-29 14:20:00 Weekly Edge Case – Lime Technologies

2026-10-29 12:22:00 Initiator Pharma: Last patient dosed, topline data now expected in February 2027

2026-10-29 12:21:00 BioArctic: Leqembi Q3 royalties in line with estimates

2026-10-29 12:20:00 GiG Software (Q3 Review): Guidance supports raised estimates

2026-10-29 12:20:00 Catella (Q3 Preview): Stronger euro, weaker deal market

2026-10-29 12:19:00 TagMaster (Q3 Review): Solid performance in a slow market

2026-10-29 12:19:00 BioInvent: SEK430m Rights Issue, but Owner Support Is Thin

2026-10-29 12:18:00 Avensia (Q3 Review): Margin recovery arrives ahead of the savings – 10% EBIT margin within reach 2027

2026-10-29 12:18:00 SSH (Q3 Review): Privileged Growth

2026-10-28 11:53:00 Magle Group: Delisting application submitted

2026-10-28 11:52:00 AlzeCure: Change of CEO as the company enters a new phase

2026-10-28 11:50:00 Xbrane Biopharma: Lucamzi approved by the FDA

2026-10-28 11:47:00 NextCell Pharma: Initial comments on the data

2026-10-28 11:46:00 Oncopeptides (Q3 Preview): Operating Leverage in Focus

2026-10-28 11:45:00 Neem’s Hill (Q3 Review): Underlying progress points to sales growth

2026-10-27 17:37:00 Camurus (Q3 preview): Expecting Continued Growth

2026-10-27 17:36:00 Safeture (Q3 Review): Trimming Estimates, Valuation Remains Attractive

2026-10-27 17:35:00 VEF (Q3 review): Solid quarter, overshadowed by Brazil

2026-10-27 12:27:00 Addnode (Q3 Review): Margin recovery arrives early, with a 2027 tailwind ahead

2026-10-27 12:26:00 Medcap Q3 2026: Margin Beat, Fair Value Trimmed

2026-10-26 15:18:00 RaySearch (Q3 preview): The moment of truth

2026-10-26 15:17:00 BioInvent: Larger Cohort Confirms BI-1808 Efficacy

2026-10-26 15:16:00 Evolution (Q3 Review): Stable quarter, Brazil creates uncertainty

2026-10-26 15:15:00 Stille Q3: Improving profitability and strong cash flow generation

2026-10-26 11:44:00 OXE Marine (Q3 Review): Upbeat Q3 but overall demand remains soft

2026-10-26 11:43:00 Gapwaves (Q3 Review): Volume beats, price lags

2026-10-26 11:42:00 Björn Borg (Q3 Review): Back on the growth track

2026-10-26 11:41:00 AVTECH (Q3 Review): First new airline pushed into 2027; value just above bear

2026-10-26 11:40:00 Modelon (Q3 Review): ARR turns – growth back on the agenda

2026-10-26 11:39:00 Ependion (Q3 Review): Operating leverage kicking in

2026-10-26 11:38:00 Vitec (Q3 Review): M&A engine set to accelerate

2026-10-23 16:42:00 Biovica: Rights issue outcome announced

2026-10-23 15:35:00 Annexin (Q3 Review): Fully recruited study

2026-10-23 14:49:00 Nanologica: New CEO, updated strategy and SEK110.5m rights issue

2026-10-23 14:48:00 ExpreS2ion Biotech: Phase I fully enrolled, readout in Q1 2027

2026-10-23 14:47:00 SSH (Q3 Preview): A Soft Quarter Expected, Focus on Order Timing

2026-10-23 14:21:00 Alligator Bioscience (Q3 Review): Partnering Mitazalimab to Fund HLX22

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode